In 71 out of 217 HCCs (32.71%), simultaneous positivity for VSIG1 and TTF-1 was seen, being more specific for G1/G2 carcinomas with a trabecular architecture and a longer OS (<i>p</i> = 0.004). This evidence concerns the gene VSIG1 and carcinoma.